Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 17.35% institutional investors, 41.59% insiders, and 41.07% retail investors. Vanguard group is the largest institutional shareholder, holding 3.72% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.50% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma17.35%41.59%41.07%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group845.50K3.72%$6.38M
Blackrock funding, inc. /de782.80K3.59%$5.91M
Iridian asset management llc/ct586.32K2.58%$4.43M
Baldwin brothers llc/ma389.63K1.72%$2.94M
Geode capital management364.02K1.67%$2.75M
State street136.72K0.64%$823.03K
Blackrock83.41K0.50%$528.00K
Northern trust106.64K0.50%$641.98K
Oppenheimer73.57K0.32%$555.42K
Susquehanna group, llp45.61K0.26%$246.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Iridian asset management llc/ct586.32K1.63%$4.43M
Baldwin brothers llc/ma389.63K0.19%$2.94M
Forbes j m & co llp59.00K0.04%$445.45K
Austin wealth management20.13K0.03%$178.11K
Oppenheimer73.57K0.01%$555.42K
Avalon trust14.00K0.01%$105.70K
Nations financial group inc, /ia/ /adv13.00K0.01%$98.15K
Xtx topco14.87K0.00%$89.49K
Nbc securities3.00K0.00%$22.65K
Edmond de rothschild15.17K0.00%$91.32M

Top Buyers

HolderShares% AssetsChange
Iridian asset management llc/ct586.32K1.63%180.70K
Vanguard group845.50K0.00%146.79K
Blackrock funding, inc. /de782.80K0.00%97.47K
Baldwin brothers llc/ma389.63K0.19%39.16K
Geode capital management364.02K0.00%38.29K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
Renaissance---42.80K
Millennium management29.70K0.00%-38.80K
Omers administration---32.88K
Qube research---30.59K

New Positions

HolderShares% AssetsChangeValue
Citadel advisors14.94K-14.94K$94.55K
Xtx topco14.87K0.00%14.87K$89.49K
Cibc private wealth group14.57K0.00%14.57K$110.03K
Tower research capital llc (trc)3.85K0.00%3.85K$23.17K
Nbc securities3.00K0.00%3.00K$22.65K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nisa investment advisors-12.00
Srs capital advisors-38.00
Point72 (difc)-49.00
Bryn mawr trust-61.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202538-30.91%3,940,7276.65%175.80%23-8.00%6-60.00%
Sep 30, 20255519.57%3,694,86214.85%177.63%25-24.24%15114.29%
Jun 30, 20254932.43%3,242,70858.40%1514.40%3650.00%7133.33%
Mar 31, 20253719.35%2,047,14054.99%1017.47%2414.29%3-62.50%
Dec 31, 202430-3.23%1,298,77823.77%720.32%2053.85%8-27.27%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv357.63K1.50%-7.89K
iShares Russell 2000 ETF261.27K1.03%-
Vanguard Institutional Extnd Mkt Idx Tr130.84K0.55%-64.53K
Fidelity Small Cap Index129.67K0.51%129.67K
iShares Russell 2000 Growth ETF108.20K0.42%-
Vanguard Russell 2000 ETF62.02K0.26%-3.50K
Fidelity Extended Market Index62.26K0.24%-512.00
State St Russell Sm Cap® Indx SL Cl I45.10K0.18%-
Schwab Small Cap Index32.38K0.14%-
NT R2000 Index Fund - NL31.13K0.13%31.13K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 05, 2025BENTSUR RON Chairman & CEOBuy$28.60K
Nov 05, 2025Sanchez Juan-Buy$75.27K
Nov 05, 2025Kaplan Matthew L.-Buy$64.24K
Oct 23, 2025Mosseri Marlio Charles-Buy$284.21K
Oct 24, 2025Mosseri Marlio Charles-Buy$215.46K

Insider Transactions Trends


DateBuySell
2025 Q46-
2025 Q218-
2025 Q11-
2024 Q461
2024 Q3--

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 17.35%, followed by 41.59% insiders and 41.06% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 384.55%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Vanguard group (845.5K shares, 3.72%), Blackrock funding, inc. /de (782.8K shares, 3.59%), and Iridian asset management llc/ct (586.32K shares, 2.58%). Together, they hold 9.89% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Iridian asset management llc/ct is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 1.63% of its assets in 586.32K Nuvectis Pharma shares, valued at 4.43M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 1.50% of its total shares outstanding invested in 357.63K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools